Effect of dexamethasone on B7 regulation and T cell activation in neonates and adults

Pediatric Research

Volumn 57, Issue 5 I, 2005, Pages 656-661

  Orlikowsky, Thorsten W ^a   Dannecker, Günther E ^b   Spring, Bärbel ^a   Eichner, Martin ^a   Hoffmann, Michael K ^c   Poets, Christian F ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b OLGAHOSPITAL   (Germany)

^c NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD86 ANTIGEN; CYCLIC AMP; DEXAMETHASONE; GAMMA INTERFERON; HLA DR ANTIGEN; MITOGENIC AGENT; MONOCLONAL ANTIBODY CD3;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CELL DAMAGE; CELL FUNCTION; CELL ISOLATION; CELL SIZE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CYTOTOXICITY; DRUG EFFECT; HUMAN; HUMAN CELL; IMMUNOPHARMACOLOGY; MACROPHAGE; NEWBORN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION; TISSUE CULTURE; UMBILICAL CORD BLOOD; UPREGULATION;

ADULT; AGE FACTORS; ANTI-INFLAMMATORY AGENTS; ANTIGENS, CD; ANTIGENS, CD28; ANTIGENS, CD3; ANTIGENS, CD80; ANTIGENS, CD86; COCULTURE TECHNIQUES; CYCLIC AMP; DEXAMETHASONE; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; INFANT, NEWBORN; INTERFERON TYPE II; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; MACROPHAGES; MALE; MEMBRANE GLYCOPROTEINS; PHENOTYPE; T-LYMPHOCYTES; TIME FACTORS; UP-REGULATION;

EID: 17744382166     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/01.PDR.0000156211.48307.F5     Document Type: Article

References (54)

1. Tsukahara H, Watanabe Y, Yasutomi M, Kobata R, Tamura S, Kimura K, Hiraoka M, Mayumi M 1999 Early (4-7 days of age) dexamethasone therapy for prevention of chronic lung disease in preterm infants. Biol Neonate 76:283-290
2. Grier DG, Halliday HL 2003 Corticosteroids in the prevention and management of bronchopulmonary dysplasia. Semin Neonatol 8:83-91
3. Li YH, Brauner A, Jonsson B, Van-der-Ploeg I, Soder O, Holst M, Jensen JS, Lagercrantz H, Tullus K 2001 Inhibition of macrophage proinflammatory cytokine expression by steroids and recombinant IL-10. Biol Neonate 80:124-132
4. Papoff P, Christensen RD, Calhoun DA, Juul SE 2001 Granulocyte colony-stimulating factor, granulocyte macrophage colony-stimulating factor and neutrophils in the bronchoalveolar lavage fluid of premature infants with respiratory distress syndrome. Biol Neonate 80:133-141
5. Bessler H, Mendel C, Straussberg R, Gurary N, Aloni D, Sirota L 1999 Effects of dexamethasone on IL-1β, IL-6, and TNF-α production by mononuclear cells of newborns and adults. Biol Neonate 75:225-233
6. Bessler H, Kagazanov S, Punsky I, Sirota L 2001 Effect of Dexamethasone on IL-10 and IL-12p40 production in newborns and adults. Biol Neonate 80:262-266
7. Aggarwal S, Gupta A, Nagata S, Gupta S 1997 Programmed cell death (apoptosis) in cord blood lymphocytes. J Clin Immunol 17:63-73
8. Kavelaars A, Zijlstra J, Bakker JM, Van Rees EP, Visser GH, Zegers BJ, Heijnen CJ 1995 Increased dexamethasone sensitivity of neonatal leukocytes: different mechanism of glucocorticoid inhibition of T cell proliferation of adult and neonatal cells. Eur J Immunol 25:1346-1351
9. Bakker JM, Kavelaars A, Kamphuis PJ, Zijlstra J, van Bel F, Heijnen CJ 2001 Neonatal dexamethasone treatment induces long-lasting changes in T-cell receptor vβ repertoire in rats. J Neuroimmunol 112:47-54
10. Parimi PS, Birnrant DJ, Rao LV, Diaz G, Moore JJ 1999 Effect of dexamethasone on lymphocyte subpopulations in premature infants with bronchopulmonary dysplasia. J Perinatol 19:347-351
11. van de Stolpe A, Caldenhoven E, Raaijmakers JA, van der Saag PT, Koenderman L 1993 Glucocorticoid-mediated repression of intracellular adhesion molecule-1 expression in human monocytic and bronchial epithelial cell lines. Am J Respir Cell Mol Biol 8:340-347
12. Irakam A, Miskolci V, Vancurova I, Davidson D 2002 Dose-related inhibition of proinflammatory cytokine release from neutrophils of the newborn by dexamethasone, betamethasone, and hydrocortisone. Biol Neonate 82:98-95
13. Orlikowsky T, Wang ZQ, Dudhane A, Dannecker GE, Niethammer D, Wormser GP, Hoffmann MK, Horowitz HW 2001 Dexamethasone inhibits CD4 T cell deletion mediated by macrophages from human immunodeficiency virus-infected individuals. J Infect Dis 184:1328-1330
14. Ridge JP, Fuchs EJ, Matzinger P 1996 Neonatal tolerance revisited: turning on newborn T cells with dendritic cells. Science 271:1723-1726
15. Hunt DW, Huppertz HI, Jiang HJ, Petty RE 1994 Studies of human cord blood dendritic cells: evidence for functional immaturity. Blood 84:4333-4343
16. Orlikowsky TW, Spring B, Dannecker GE, Niethammer D, Poets CF, Hoffmann MK 2003 Expression and regulation of B7 family molecules on macrophages (MPhi) in preterm and term neonatal cord blood and peripheral blood of adults. Cytometry 53B:40-47
17. Schwartz RH 1992 Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy. Cell 71:1065-1068
18. Janeway CA Jr, Bottomly K 1994 Signals and signs for lymphocyte responses. Cell 76:275-285
19. Kuchroo VK, Das MP, Brown JA, Ranger AM, Zamvil SS, Sobel RA, Weiner HL, Nabavi N, Glimcher LH 1995 B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 80:707-718
20. Nabavi N, Freeman GJ, Gault A, Godfrey D, Nadler LM, Glimcher LH 1992 Signalling through the MHC class II cytoplasmic domain is required for antigen presentation and induces B7 expression. Nature 360:266-268
21. Linsley PS, Greene JL, Brady W, Bajorath J, Ledbetter JA, Peach R 1994 Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4-receptors. Immunity 1:793-797
22. Salomon B, Bluestone JA 2001 Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation. Annu Rev Immunol 19:225-252
23. Azuma M, Ito D, Yagita H, Okumura K, Phillips JH, Lanier LL, Somoza C 1993 B70 antigen is a second ligand for CTLA-4 and CD28. Nature 366:76-79
24. Schmittel A, Scheibenbogen C, Kielholz U 1995 Lipopolysaccharide effectively upregulates B7-1 (CD80) expression and costimulatory function of human monocytes. Scand J Immunol 42:701-704
25. Orlikowsky T, Wang ZQ, Dudhane A, Horowitz HH, Conti B, Hoffmann MK 1997 Two distinct pathways of human macrophage differentiation are mediated by interferon-gamma and interleukin-10. Immunol 91:104-108
26. Hathcock KS, Laszlo G, Pucillo C, Linsley PS, Hodes RJ 1994 Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression and function. J Exp Med 180:631-640
27. Girndt M, Sester U, Kaul H, Hünger F, Köhler H 1998 Glucocorticoids inhibit activation-dependent expression of costimulatory molecule B7-1 in human monocytes. Transplantation 66:370-375
28. Orlikowsky T, Dannecker GE, Wang Z, Horowitz H, Niethammer D, Hoffmann MK 1999 Activation or destruction of T cells via macrophages. Pathobiology 67:298-301
29. Linsley PS, Ledbetter JA 1993 The role of the CD28 receptor during T cell responses to antigen. Annu Rev Immunol 11:191-212
30. Wang ZQ, Orlikowsky T, Dudhane A, Trejo V, Hoffmann MK 1998 Macrophages may activate or destroy T cells with which they form antigen- or coreceptor-mediated cellular conjugates. Cell Immunol 189:74-82
31. Kümmerle-Deschner JB, Hoffmann MK, Niethammer D, Dannecker GE 1998 Pediatric rheumatology: autoimmune mechanisms and therapeutic strategies. Immunol Today 19:250-253
32. Ding L, Linsley PS, Huang LY, Germain RN, Shevach EM 1993 IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the upregulation of B7 expression. J Immunol 151:1224-1234
33. Wang ZQ, Bapat AS, Rayanade RJ, Dagtas AS, Hoffmann MK 2001 Interleukin-10 induces macrophage apoptosis and expression of CD16 (FcγRIII) whose engagement blocks the cell death programme and facilitates differentiation. Immunology 102:331-337
34. Trinchieri G 1997 Cytokines acting on or secreted by macrophages during intracellular infection (IL-10, IL-12, IFN-gamma). Curr Opin Immunol 9:17-23
35. Wilder RL, Elenkov IJ 1999 Hormonal regulation of tumor necrosis factor-alpha, interleukin-12 and interleukin-10 production by activated macrophages. A disease-modifying mechanism in rheumatoid arthritis and systemic lupus erythematosus? Ann NY Acad Sci 876:14-31
36. Kataoka Y, Iwasaki T, Kuroiwa T, Seto Y, Iwata N, Hashimoto N, Ogata A, Hamano T, Kakishita E 2001 The role of donor T cells for target organ injuries in acute and chronic graft-versus-host disease. Immunology 103:310-318
37. Wang Z, Horowitz HW, Orlikowsky T, Hahn BI, Trejo V, Bapat AS, Mittler RS, Rayanade RJ, Yang SY, Hoffmann MK 1999 Polyspecific self-reactive antibodies in individuals infected with human immunodeficiency virus facilitate T cell deletion and inhibit costimulatory accessory cell function. J Infect Dis 180:1072-1079
38. Wang ZQ, Horowitz HW, Orlikowsky T, Dudhane A, Weinstein A, Hoffmann MK 1998 Lymphocyte-reactive autoantibodies in human immunodeficiency virus type 1-infected persons facilitate the deletion of CD8 T cells by macrophages. J Infect Dis 178:404-412
39. Wang ZQ, Bapat AS, Trejo V, Orlikowsky T, Mittler RS, Hoffmann MK 1999 MHC class I molecules on CD4 T cells regulate receptor-mediated activation signals. Cell Immunol 193:108-114
40. Sperling AI, Auger JA, Ehst BD, Rulifson IC, Thompson CB, Bluestone JA 1996 CD28/B7 interactions deliver a unique signal to naive T cells that regulates cell survival but not early proliferation. J Immunol 157:3909-3917
41. Hurtado JC, Kim YJ, Kwon BS 1997 Signals through 4-1BB are costimulatory to previously activated splenic T cells and inhibit activation-induced cell death. J Immunol 158:2600-2609
42. Orlikowsky T, Wang ZQ, Dudhane A, Horowitz HW, Riethmuller G, Hoffmann MK 1997 Cytotoxic monocytes in the blood of HIV type 1-infected subjects destroy targeted T cells in a CD95-dependent fashion. AIDS Res Hum Retroviruses 13:953-960
43. Wang Z, Horowitz HW, Orlikowsky T, Hahn BI, Trejo V, Bapat AS, Mittler RS, Rayanade RJ, Yang SY, Hoffmann MK 1999 Polyspecific self-reactive antibodies in individuals infected with human immunodeficiency virus facilitate T cell deletion and inhibit costimulatory accessory cell function. J Infect Dis 180:1072-1079
44. Dudhane A, Conti B, Orlikowsky T, Wang ZQ, Mangla N, Gupta A, Wormser GP, Hoffmann MK 1996 Monocytes in HIV type 1-infected individuals lose expression of costimulatory B7 molecules and acquire cytotoxic activity. AIDS Res Hum Retroviruses 12:885-892
45. Kiener PA, Davis PM, Rankin BM, Klebanoff SJ, Ledbetter JA, Starling GC, Liles WC 1997 Human monocytic cells contain high levels of intracellular Fas ligand: rapid release following cellular activation. J Immunol 159:1594-1598
46. Stiehm ER, Sztein MB, Steeg PS, Mann D, Newland C, Blaese M, Oppenheim JJ 1984 Deficient DR antigen expression on human cord blood monocytes: reversal with lymphokines. Clin Immunol Immunopathol 30:430-436
47. Taylor S, Bryson YJ 1985 Impaired production of gamma-interferon by newborn cells in vitro is due to a functionally immature macrophage. J Immunol 134:1493-1497
48. Marodi L 2002 Deficient interferon-gamma receptor-mediated signaling in neonatal macrophages. Acta Paediatr Suppl 91:117-119
49. Birle A, Nebe TC, Gessler P 2003 Age-related low expression of HLA-DR molecules on monocytes of term and preterm newborns with and without signs of infection. J Perinatol 23:294-299
50. Schwiebert LM, Schleimer RP, Radka SF, Ono SJ 1995 Modulation of MHC class II expression in human cells by dexamethasone. Cell Immunol 165:12-19
51. Wakasugi N, Virelizier JL 1985 Defective IFN-γ production in the human neonate. I. Dysregulation rather than intrinsic abnormality. J Immunol 134:167-171
52. Arya SK, Wong-Staal F, Gallo RC 1984 Dexamethasone-mediated inhibition of human T cell growth factor and gamma-interferon messenger RNA. J Immunol 133:273-276
53. Munck A, Guyre PM 1990 Psychoneuroendocrinology, 2nd Ed. Acad Press, San Diego, pp 447-461
54. Rosenfeld P, Van Eekelen JA, Levine S, de Kloet ER 1993 Ontogeny of glucocorticoid receptors in the brain. Cell Mol Neurobiol 13:261-277